Navigation Links
Luminex Corporation Reports Second Quarter 2012 Results
Date:7/30/2012

pleased with our second quarter results and long-term trajectory. Luminex's strategic plan is focused on providing customers with the tools they need to positively impact human health through reduced complexity and increased speed of the testing process. We continue to invest heavily in our proprietary xMAP® technology, and we have always recognized that one platform may not suit all lab customer needs. In order to access these new opportunities, Luminex has sought to acquire external technologies, such as EraGen Biosciences in 2011 and our recent acquisition of GenturaDx," said Patrick J. Balthrop, president and chief executive officer of Luminex.  "We are excited about GenturaDx technology and believe its simple to use, sample-to-answer platform combined with our proprietary MultiCode RTx chemistry will provide hospital-based molecular diagnostic labs with another powerful tool in their search for answers. When this system is commercialized (anticipated for 2014) Luminex will be able to offer our customers with a broad line of product solutions to fit their specific needs." 

"Regarding new product updates, I am pleased to report that Luminex has submitted a de-novo 510(k) application to the FDA for our gastrointestinal pathogen panel (xTAG® GPP) assay. This product offering addresses a sizeable new market opportunity for Luminex and is another example of how Luminex is providing advanced solutions and real value to our customers. With new assays like GPP, NeoPlex4 and the exciting portfolio from Luminex Madison, we are positioned for strong growth in the future," Balthrop concluded. 

 REVENUE SUMMARY(in thousands, except percentages)Three Months EndedJune 30,Variance20122011($)(%)(unaudited)System sales

$   8,386$   9,135$
(749)-8%Consumable sales

10,80218,397(7,595)-41%Royalty revenue

7,7157,4123034%Assay revenue

17,5109,2618,24989%All other revenue

3,8603,43342
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
2. Luminex Corporation Announces Agreement to Acquire GenturaDx
3. Luminex Corporation Reports First Quarter 2012 Results
4. Unilife Corporation Announces Financial Results For Fiscal Year 2012 Fourth Quarter
5. Gentris Corporation Announces Collaboration to Study Blood Stability
6. Unilife Corporation to Announce Financial Results for Fiscal 2012 Fourth Quarter and Year End on Monday, July 30, 2012
7. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
8. Celladon Corporation Receives Patent from United States Patent and Trademark Office
9. Gentris Corporation Launches New Pharmacogenomics Services
10. BioElectronics Corporation Announces Initiative for UK and German Markets
11. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... ORLANDO, Fla. , May 22, 2015 ... Copay Assistance Program. This program provides financial assistance for ... "We are pleased to announce the addition of the ... programs," stated Mark McGreevy , executive director. "With ... mission and vision of a world where no one ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... tissue protection, repair and regeneration, today announced that ... scheduled to present a corporate overview at two upcoming ... at the SeeThruEquity 4 th Annual Microcap Conference ... York City at 11:00 am EDT.  A ...
(Date:5/22/2015)... WASHINGTON , May 22, 2015  The ... certain diagnosed victims of mesothelioma get the best ... making certain individuals with this rare cancer caused ... the most up-to-date information related to treatment options ... information please call the Mesothelioma Victims Center anytime ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... Australia, Feb. 19 Phosphagenics,Limited ("Phosphagenics") (ASX: POH; ... a human clinical trial for its lead,dermatological product, ... trial,represents the Company,s first clinical trial to take ... the Company,s planned expansion into targeted,non-systemic delivery of ...
... ADELAIDE and COPENHAGEN, Feb. 19 Bionomics,Limited (ASX: ... completion,of pre-clinical testing on the first of eight ... Genmab A/S (OMX: GEN), triggering a US $1,million ... executed in February 2006, Genmab,acquired the exclusive worldwide ...
Cached Medicine Technology:Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid 2Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid 3Bionomics Achieves US$1 Million Milestone Payment from Genmab 2Bionomics Achieves US$1 Million Milestone Payment from Genmab 3
(Date:5/24/2015)... Medicx Media Solutions http://www.medicxmedia.com ... Jay Krihak as its head of programmatic strategy ... its expertise and leadership position in the data ... sectors. , Krihak is an experienced, award-winning agency ... led sales planning teams for mobile platform Jumptap. ...
(Date:5/23/2015)... On Saturday, May 23, 2015, over 100 ... Branches Florida City exactly five years to the day after ... , A large fire tore through the Branches United Methodist ... in the middle of the night as neighbors, staff and ... arson even though it is suspected that the fire began ...
(Date:5/23/2015)... CA (PRWEB) May 23, 2015 With ... small businesses, are finding it increasingly difficult to provide ... which fail to provide adequate insurance for employees stand ... businesses been such an integral part of a business’s ... affordable healthcare for businesses, Online USA Doctors has created ...
(Date:5/23/2015)... May 23, 2015 Manufacturers are now required ... Factor (HSPF) of 8.2. Experts in the field agree that ... consumers. , The HSPF score is what miles per gallon ... efficient the unit. Although the minimum HSPF score has been ... with an HSPF score north of 12. Indeed, the regulation ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ... It's as simple as dragging and dropping footage into the ... full effect. , Including over 80 stunning flares, ProFlare ... making this the ultimate bundle for adding prismatic refractions to ... package are movie files designed for Final Cut Pro X, ...
Breaking Medicine News(10 mins):Health News:Medicx Media Solutions Expands Executive Team 2Health News:Five Years After Fire, Branches Rebuilds Playground 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2
... , FRANKLIN, Mass., July 27 PLC Systems ... cardiac and vascular medical device-based technologies, today announced it has ... provided by RenalGuard(R) from the Canadian Intellectual Property Office (CIPO) ... for RenalGuard in Canada. , , Mark ...
... , ABBOTT PARK, Ill., July 27 ... resolving all outstanding intellectual property litigation between the two parties. ... Medtronic will pay Abbott $400 million. The settlement also includes a ... vascular products, subject to specific conditions and time limits. Additional terms ...
... , , ... for Health Care Reform will hold three (3) rallies this week to ... health care reform debate is being stalled because of partisanship and political ... and underinsured Americans who suffer daily because of escalating health care costs ...
... increase in gastrointestinal problems in kids with the disorder ... autism do not have a higher incidence of gastrointestinal ... , However, autistic children do have a higher rate ... same foods over and over, according to the study. ...
... , , , ... today announced that it has expanded the treatment capabilities of the ... skin cancer trial to further prove the safety and feasibility for ... American Association of Physicists in Medicine (AAPM) Meeting. The Company ...
... MINNEAPOLIS, July 27 Premier Visiting Nurse, part ... entered into a business relationship with Cardiocom (R) ... chronic illness. Cardiocom, the Experts in Telehealth(SM), is ... of award-winning telehealth solutions. , , ...
Cached Medicine News:Health News:Canada Grants PLC Systems First Patent for RenalGuard(R) 2Health News:Delaying Health Care Reform is U-N-A-C-C-E-P-T-A-B-L-E! 2Health News:With Autism, Diet Restrictions May Do More Harm Than Good 2Health News:With Autism, Diet Restrictions May Do More Harm Than Good 3Health News:Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 2Health News:Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 3Health News:Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 4Health News:Premier Visiting Nurse Selects Cardiocom Telehealth Technology 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: